Pharmala is focused on manufacture of Active Pharmaceutical Ingredients, of the Substituted methylenedioxy- phenethylamines class (“MDXX”), including 3,4-Methylenedioxymethamphetamine (“MDMA”). Pharmala also intends to undertake development of novel formulations of MDMA and the MDXX class of compounds, as well as developing novel drug delivery pathways for these molecules.

As an innovative, vertically integrated and established cannabis leader in the Nevada market, Planet 13 Holdings, Inc. is committed to providing an array of international award-winning cannabis products available through its strategically located licensed operations. Planet 13 Holdings, Inc. is focused on providing an unparalleled dispensary experience and optimizing cultivation efficiencies through its best-in-class technology, as the vanguard of cannabis.

PreveCeutical Medical Inc. (CSE: PREV) is a health sciences company that develops innovative options for preventive and curative therapies utilizing nature and nature identical products.

Psyched Wellness Ltd. is a Canadian-based health supplements company dedicated to the distribution of mushroom-derived products and associated consumer packaged goods. The Company’s objective is to create premium mushroom-derived products that have the potential to become a leading North American brand in the emerging functional food category.  The Company is in the process of developing a line of Amanita muscaria-derived water-based extracts, teas and capsules designed to help with three health objectives: promote stress relief and relaxation, assist with sleeping and to support mood.